---
figid: PMC7224649__gr1
figlink: pmc/articles/PMC7224649/figure/f0005/
number: F1
caption: This diagram shows the classic signaling pathway (mediated by the membrane-bound
  form of IL-6 receptor, mIL6R) which is believed to be the anti-inflammatory one
  and the trans-signaling pathway (mediated by the soluble form of IL-6 receptor,
  sIL6-R) which is believed to be the pro-inflammatory one. Tocilizumab inhibits both
  of them, SGP130Fc inhibits only the trans-signaling pathway.
pmcid: PMC7224649
papertitle: 'SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’
  of ARDS onset? What is there besides Tocilizumab? SGP130Fc.'
reftext: Giuseppe Magro. Cytokine X. 2020 Jun;2(2):100029.
pmc_ranked_result_index: '24149'
pathway_score: 0.9507474
filename: gr1.jpg
figtitle: 'SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of
  ARDS onset? What is there besides Tocilizumab? SGP130Fc'
year: '2020'
organisms:
- Mus musculus
- Coronaviridae
- Orthomyxoviridae
- Influenza A virus
- H1N1 subtype
- Respiratory syncytial virus
- Middle East respiratory syndrome-related coronavirus
- Listeria monocytogenes
- Severe acute respiratory syndrome coronavirus 2
- Betacoronavirus
- Severe acute respiratory syndrome-related coronavirus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7224649__gr1.html
  '@type': Dataset
  description: This diagram shows the classic signaling pathway (mediated by the membrane-bound
    form of IL-6 receptor, mIL6R) which is believed to be the anti-inflammatory one
    and the trans-signaling pathway (mediated by the soluble form of IL-6 receptor,
    sIL6-R) which is believed to be the pro-inflammatory one. Tocilizumab inhibits
    both of them, SGP130Fc inhibits only the trans-signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - Ruxolitinib
  - Baricitinib
  - SIL
genes:
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
chemicals:
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Baricitinib
  source: MESH
  identifier: C000596027
diseases:
- word: SIL
  source: ''
  identifier: ''
figid_alias: PMC7224649__F1
redirect_from: /figures/PMC7224649__F1
figtype: Figure
---
